Fosinopril Sodium NDC 62135-043

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-043Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0043Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-043-90	62135004390	90 TABLET in 1 BOTTLE (62135-043-90)Marketed from Jun 1, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fosinopril Sodium
Generic name (nonproprietary): fosinopril sodium
Active ingredients: Fosinopril sodium — 40 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076483
Marketing start: Apr 23, 2004
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)
Identifiers: Product ID 62135-043_40d2b698-02dc-4589-e063-6394a90afb52SPL ID 40d2b698-02dc-4589-e063-6394a90afb52SPL set ID ff1323cc-7ad8-488d-94a7-a11555db78a7RxCUI 857169, 857183, 857187UNII NW2RTH6T2NUPC 0362135042905, 0362135043902, 0362135041908
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135004390 followed by a unit qualifier and the quantity

Package 62135-0043-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 10, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Fosinopril sodium tablets are indicated for the treatment of hypertension. They may be used alone or in combination with thiazide diuretics. Fosinopril sodium tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see DOSAGE AND ADMINISTRATION ) . In using fosinopril sodium tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. Available data are insufficient to show that fosinopril sodium tablets do no…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076483

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076483
Product	Strength	Form · route	Labeler	Product NDC
Fosinopril Sodium	Fosinopril sodium 10 mg/1	TabletOral	Chartwell RX, LLC	62135-041
Fosinopril Sodium	Fosinopril sodium 20 mg/1	TabletOral	Chartwell RX, LLC	62135-042